IL154202A0 - Pharmaceutical compositions for treating anorectal disorders - Google Patents
Pharmaceutical compositions for treating anorectal disordersInfo
- Publication number
- IL154202A0 IL154202A0 IL15420201A IL15420201A IL154202A0 IL 154202 A0 IL154202 A0 IL 154202A0 IL 15420201 A IL15420201 A IL 15420201A IL 15420201 A IL15420201 A IL 15420201A IL 154202 A0 IL154202 A0 IL 154202A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- anorectal disorders
- treating anorectal
- treating
- disorders
- Prior art date
Links
- 208000015815 Rectal disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22226700P | 2000-07-31 | 2000-07-31 | |
| PCT/US2001/023971 WO2002009714A1 (en) | 2000-07-31 | 2001-07-30 | Compositions and methods for the treatment of anorectal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154202A0 true IL154202A0 (en) | 2003-07-31 |
Family
ID=22831555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15420201A IL154202A0 (en) | 2000-07-31 | 2001-07-30 | Pharmaceutical compositions for treating anorectal disorders |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1315499A4 (es) |
| JP (1) | JP2004516244A (es) |
| KR (3) | KR20100017750A (es) |
| AU (1) | AU2001279104A1 (es) |
| CA (1) | CA2417848A1 (es) |
| IL (1) | IL154202A0 (es) |
| MX (1) | MXPA03000931A (es) |
| WO (1) | WO2002009714A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0020588D0 (en) * | 2000-08-21 | 2000-10-11 | Pfizer Ltd | Treatment of wounds |
| US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
| US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
| KR101067443B1 (ko) | 2009-06-23 | 2011-09-27 | 여오영 | 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 |
| CN102145004B (zh) * | 2010-02-09 | 2012-03-21 | 鲁南制药集团股份有限公司 | 己酮可可碱在制备预防或治疗功能性便秘的药物中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595753A (en) | 1995-04-14 | 1997-01-21 | President And Fellows Of Harvard College | Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract |
| CN1298309A (zh) * | 1998-02-27 | 2001-06-06 | 同步神经元有限责任公司 | 治疗肛门区疼痛的方法及其组合物 |
| AU764921B2 (en) * | 1998-12-14 | 2003-09-04 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
-
2001
- 2001-07-30 KR KR1020097025777A patent/KR20100017750A/ko not_active Application Discontinuation
- 2001-07-30 WO PCT/US2001/023971 patent/WO2002009714A1/en not_active Application Discontinuation
- 2001-07-30 KR KR1020037001579A patent/KR100863758B1/ko not_active IP Right Cessation
- 2001-07-30 KR KR1020087015829A patent/KR20080068145A/ko not_active Application Discontinuation
- 2001-07-30 EP EP01957348A patent/EP1315499A4/en not_active Withdrawn
- 2001-07-30 AU AU2001279104A patent/AU2001279104A1/en not_active Abandoned
- 2001-07-30 MX MXPA03000931A patent/MXPA03000931A/es unknown
- 2001-07-30 JP JP2002515267A patent/JP2004516244A/ja not_active Withdrawn
- 2001-07-30 CA CA002417848A patent/CA2417848A1/en not_active Abandoned
- 2001-07-30 IL IL15420201A patent/IL154202A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004516244A (ja) | 2004-06-03 |
| CA2417848A1 (en) | 2002-02-07 |
| WO2002009714A1 (en) | 2002-02-07 |
| KR100863758B1 (ko) | 2008-10-16 |
| AU2001279104A1 (en) | 2002-02-13 |
| WO2002009714A9 (en) | 2003-03-06 |
| EP1315499A4 (en) | 2007-09-05 |
| MXPA03000931A (es) | 2004-08-12 |
| KR20080068145A (ko) | 2008-07-22 |
| KR20030024826A (ko) | 2003-03-26 |
| KR20100017750A (ko) | 2010-02-16 |
| EP1315499A1 (en) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101627A3 (en) | Pharmaceutical compositions for treating neuropsychiatric disorders | |
| EG24357A (en) | New Pharmaceutical composition | |
| GB2358583B (en) | Pharmaceutical compositions | |
| HUP0300582A3 (en) | Pharmaceutical compositions | |
| AU6219601A (en) | Pharmaceutical compositions | |
| GB0009584D0 (en) | Pharmaceutical compositions | |
| AU8576801A (en) | Pharmaceutical compositions | |
| HUP0400553A3 (en) | Pharmaceutical compositions | |
| AU4154402A (en) | Herbal pharmaceutical compositions for treating immunological disorders | |
| AU1390002A (en) | Pharmaceutical compositions | |
| GB0008485D0 (en) | Pharmaceutical compositions | |
| HUP0301553A3 (en) | Pharmaceutical compositions and their use for treating neurological disorders | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| IL154202A0 (en) | Pharmaceutical compositions for treating anorectal disorders | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| GB0002691D0 (en) | Pharmaceutical composition | |
| GB0008872D0 (en) | Pharmaceutical compositions | |
| GB0031288D0 (en) | Pharmaceutical compositions | |
| GB0031282D0 (en) | Pharmaceutical compositions | |
| GB0000062D0 (en) | Pharmaceutical compositions | |
| HU0700204D0 (en) | Pharmaceutical compositions | |
| GB0003929D0 (en) | Pharmaceutical compositions | |
| GB0018321D0 (en) | Pharmaceutical compositions | |
| GB0001337D0 (en) | Pharmaceutical compositions | |
| GB0016684D0 (en) | Pharmaceutical composition |